Anti-obesity medications: gastrointestinal adverse events common

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2025年 / 2046卷 / 1期
关键词：
D O I：
10.1007/s40278-025-77390-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [31] Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease
    Stergios A. Polyzos
    Dimitrios G. Goulis
    Olga Giouleme
    Georgios S. Germanidis
    Antonis Goulas
    Current Obesity Reports, 2022, 11 : 166 - 179
  • [32] PRIMARY CARE PERSPECTIVES ON PRESCRIBING ANTI-OBESITY MEDICATIONS FOR ADOLESCENTS
    Chivate, Rutha
    Schoemer, Pamela
    Ray, Kristin
    Ragavan, Maya
    Bensignor, Megan
    Goldschmidt, Andrea
    Vajravelu, Mary Ellen
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 268 - 270
  • [33] Ischemic colitis after mesotherapy combined with anti-obesity medications
    Jong Bin Kim
    Won Moon
    Seun Ja Park
    Moo In Park
    Kyu-Jong Kim
    Jae Nam Lee
    Seong Joo Kang
    Lee La Jang
    Hee Kyung Chang
    World Journal of Gastroenterology, 2010, 16 (12) : 1537 - 1540
  • [34] Anti-obesity Medications: Ethical, Policy, and Public Health Concerns
    Klitzman, Robert
    Greenberg, Henry
    HASTINGS CENTER REPORT, 2024, 54 (03) : 6 - 10
  • [35] EFFECTIVENESS OF ANTI-OBESITY MEDICATIONS IN "REAL WORLD" CLINICAL PRACTICE
    Calderon, Gerardo
    Hurtado, Maria D.
    Valencia, Oscar A. Garcia
    Gonzalez-Izundegui, Daniel
    Sharma, Mayank
    Shah, Meera
    Hurley, Daniel L.
    Abu-Lebdeh, H. S.
    Schmitz, Kristine
    Clark, Matthew
    Grothe, Karen
    Mundi, Manpreet
    Jensen, Michael D.
    Abu Dayyeh, Barham K.
    Collazo-Clavell, Maria L.
    Camilleri, Michael
    Acosta, Andres
    GASTROENTEROLOGY, 2019, 156 (06) : S931 - S931
  • [36] Eligibility for Anti-Obesity Medications through Medicare for Older Adults with Overweight or Obesity
    Chetty, Ashwin K.
    Khunte, Mihir
    Chen, Alissa S.
    Jastreboff, Ania M.
    Krumholz, Harlan M.
    Lu, Yuan
    AMERICAN HEART JOURNAL, 2024, 278
  • [37] Weight a Minute: the Role of Emergent Anti-obesity Medications in the Management of Severe Obesity
    Masrur, Mario A.
    Laos, Emiliano G. Manueli
    Ducas, Alvaro
    Pirzada, Amber
    Schlottmann, Francisco
    OBESITY SURGERY, 2024, 34 (07) : 2685 - 2687
  • [38] A narrative review of anti-obesity medications for obese patients with osteoarthritis
    Oo, Win Min
    Mobasheri, Ali
    Hunter, David J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (12) : 1381 - 1395
  • [39] Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    Giouleme, Olga
    Germanidis, Georgios S.
    Goulas, Antonis
    CURRENT OBESITY REPORTS, 2022, 11 (03) : 166 - 179
  • [40] THE RELATIVE VALUE OF ANTI-OBESITY MEDICATIONS COMPARED TO SIMILAR THERAPIES
    Kim, N.
    Estrada, J.
    Chow, I
    Ruseva, A.
    Ramasamy, A.
    Burudpakdee, C.
    Blanchette, C. M.
    VALUE IN HEALTH, 2022, 25 (07) : S348 - S349
12345